Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI

NCT01005251 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

661

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease
Heartburn
Regurgitation

Interventions

DRUG: lesogaberan (AZD3355)
DRUG: lesogaberan (AZD3355)
DRUG: lesogaberan (AZD3355)
DRUG: lesogaberan (AZD3355)
DRUG: Placebo

Sponsor

AstraZeneca